Jvl Associates LLC Novartis Ag Transaction History

Jvl Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 05, 2022	SELL	$80.11 - $90.62 $127,775 - $144,538	-1,595 Reduced 32.58%	3,300 $290,000
Q3 2020 Mar 08, 2022	SELL	$82.14 - $91.0 $12,321 - $13,650	-150 Reduced 2.97%	4,895 $426,000
Q2 2020 Mar 08, 2022	SELL	$80.93 - $91.1 $20,232 - $22,775	-250 Reduced 4.72%	5,045 $441,000
Q4 2017 Mar 08, 2022	BUY	$72.33 - $77.64 $382,987 - $411,103	5,295	5,295 $445,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $228B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Jvl Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jvl Associates LLC with notifications on news.